TL;DR
This paper introduces a novel, non-invasive optical method to assess cerebral autoregulation (CA) by measuring cerebrovascular impedance (CVI) at cardiac frequencies. By demonstrating that CVI changes predictably with cerebral perfusion pressure (CPP) and can identify the limits of CA, this work offers a promising new biomarker for brain health.
What Problem Does This Paper Address?
Cerebral autoregulation (CA) is the brain's crucial ability to maintain a stable blood flow despite fluctuations in blood pressure. When CA fails, it can lead to serious neurological conditions like stroke or traumatic brain injury. Current methods to assess CA, such as analyzing the relationship between cerebral blood flow (CBF) and cerebral perfusion pressure (CPP) over slow time scales (Lassen's curve), are often invasive or lack the temporal resolution to capture dynamic changes. The authors aim to develop a non-invasive method to characterize CA by leveraging cerebrovascular impedance (CVI) at the faster, cardiac frequency, which is not influenced by active vasomotor responses, thus providing a more direct measure of the vascular system's mechanical properties.
Methods
The core of this work is a custom-built, combined Diffuse Correlation Spectroscopy (DCS) and Near-Infrared Spectroscopy (NIRS) device.
- DCS was used to measure pulsatile cerebral blood flow (CBF).
- NIRS was used to measure pulsatile changes in total hemoglobin concentration (ΔHbT), which served as a surrogate for pulsatile blood volume changes and, by extension, pulsatile cerebral perfusion pressure (CPP).
- The device synchronized DCS and NIRS measurements at a high temporal resolution (500 Hz) to capture cardiac frequencies.
- Cerebrovascular impedance (CVI) was calculated as the ratio of the spectral pressure (derived from ΔHbT) to the spectral flow (derived from CBF) at cardiac frequencies and their harmonics.
- Cerebral perfusion pressure (CPP) was modulated in non-human primates by manipulating intracranial pressure (ICP) and arterial blood pressure (ABP).
- The relationship between the calculated CVI and CPP was then analyzed to identify the limits of autoregulation.
Datasets
The study utilized data collected from three non-human primates (cynomolgus macaques). No pre-existing datasets were used for training or evaluation.
Key Insights and Ideas
- CVI as a dynamic CA marker: The study demonstrates that cerebrovascular impedance, measured at cardiac frequencies, changes predictably with cerebral perfusion pressure and can serve as a dynamic indicator of cerebral autoregulation.
- Non-invasive potential: By using diffuse optical methods (DCS and NIRS), the approach offers a non-invasive alternative to existing methods for assessing CA, which often require invasive pressure measurements.
- Cardiac frequency is key: Measuring impedance at cardiac frequencies bypasses the active vasomotor responses that influence slower CBF changes, providing a more direct assessment of the vascular system's mechanical properties.
- Identifying autoregulation limits: The CVI-CPP relationship successfully identified the lower and upper limits of autoregulation, mirroring findings from traditional Lassen's curves.
Key Results
- The combined DCS-NIRS device successfully recorded pulsatile CBF and total hemoglobin changes for extended periods in three non-human primates.
- Modulating CPP by altering ICP and ABP allowed for the reconstruction of both Lassen's autoregulation curves and the impedance index curves.
- The CBV-based impedance index showed a positive trend with CPP within the autoregulatory limits (approximately 60-72 mmHg) and a negative trend outside these limits, indicating the exhaustion of autoregulatory capacity.
- The CPP-based impedance index showed similar trends below the lower limit of autoregulation but differed above the upper limit, suggesting that co-localized measurements (CBV-based) are more accurate.
Limitations and Future Work
- Invasive CPP measurement: A significant limitation is the reliance on invasive measurements of ICP and ABP to modulate and determine CPP. The authors suggest that future work could explore non-invasive ICP estimation techniques.
- Relative measurements: The current method estimates relative changes in CVI, CBV, and CBF. To quantify absolute impedance, absolute measurements of flow and pressure would be required.
- Modulating CPP: The method requires modulating CPP to reconstruct the impedance-autoregulation curve. This might be challenging in critically ill patients where wide CPP changes are not well-tolerated. However, the authors propose that even relative changes in impedance could provide a binary assessment of autoregulation status.
- Future directions: The authors envision combining their optical method with non-invasive ICP estimation techniques to achieve a fully non-invasive assessment of cerebral autoregulation. They also suggest exploring the use of this method for binary assessment of autoregulation in patients where wide CPP modulation is not feasible.
Summary updated